Copyright 2003 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2003
A 76-YEAR-OLD white woman (patient 1), who had taken minocycline hydrochloride for 12 years to treat bronchiectasis, demonstrated gray scleral pigmentation(Figure 1 and Figure 2). Patient 2, a 70-year-old white woman, was noted to have conjunctival pigmented inclusions on routine ophthalmic evaluation after a 5-year history of minocycline use for rheumatoid arthritis (Figure 3). There were no pigmentations of the cornea, sclera, or lens. Both maculae contained discrete, unusual-appearing pigment clumps of the retinal pigment epithelium (Figure 4), unlike the pigmentations characteristic of age-related macular degeneration. A fluorescein angiogram revealed blocking of the background fluorescence by the pigment clumps. Both patients denied having used mascara or eyedrops to treat glaucoma. Light microscopic evaluation of conjunctival inclusions confirmed the presence of eosinophilic amorphous concretions with yellow autofluorescence(Figure 5), characteristic of tetracycline therapy.
Bradfield YS, Robertson DM, Salomao DR, Link TP, Rostvold JA. Minocycline-Induced Ocular Pigmentation. Arch Ophthalmol. 2003;121(1):144. doi:10.1001/archopht.121.1.144